Four-week direct-acting antiviral prophylaxis for kidney transplantation from hepatitis c-viremic donors to hepatitis c-negative recipients: An open-label nonrandomized study
Date:
01/15/2021
Citation:
Durand CM, Barnaba B, Yu S, Brown DM, Chattergoon MA, Bair N, Naqvi FF, Sulkowski M, Segev DL, Desai NM. Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study. Ann Intern Med. 2021 Jan;174(1):137-138. doi: 10.7326/M20-1468. Epub 2020 Sep 8. PMID: 32894697; PMCID: PMC8288461.
Abstract
No abstract available